ASA Lloyds Pharmacy

Lloyds Pharmacy to alter premature ejaculation landing page to make clearer mandatory doctor consultation, rules ASA

Author

By John McCarthy, Opinion Editor

March 4, 2015 | 2 min read

Lloyds Pharmacy has come under fire from the Advertising Standards Authority (ASA) after Pharmacy2U complained it misled the public to the ease with which premature ejaculation treatments could be acquired on its website.

The Lloyds Pharmacy website breached advertising standards with a header on its premature ejaculation landing page which said “Know exactly what you want. Pick a treatment below” before listing five treatments.

The information alluded that that consumers could select their treatment – without first consulting a doctor. The ASA upheld the complaint stating that the Lloyds Pharmacy website promoted prescription only medicines (POM) in an unclear manner.

An ASA statement said: “After selecting a POM, consumers were required to go through the GP consultation prior to purchase in order to assess suitability.

“We considered that the web page therefore presented the POMs as a choice for the consumer to select prior to GP consultation, as opposed to the potential outcome of that consultation and subsequently advertised POMs to the public.”

The watchdog actioned that Lloyds should ensure the ad does not appear again in its current form and that the firm should watch how it promotes POMs on its site.

ASA Lloyds Pharmacy

More from ASA

View all

Trending

Industry insights

View all
Add your own content +